Concepedia

Shoji Takagaki

ST

Statistics

Publications

3

Citations

68

H-Index

3

Active since

1998

Affiliations

Mochida Pharmaceutical (Japan)(Current)

Fujisawa City Hospital

Shoji Takagaki is an author at Mochida Pharmaceutical (Japan) specializing in pharmacokinetics of anticancer drugs, pharmacology, and chemotherapy.

Publications per year

1998–2010

3

Publications

3

AS1387392, a novel immunosuppressive cyclic tetrapeptide compound with inhibitory activity against mammalian histone deacetylase

Satoshi Sasamura, Kazutoshi Sakamoto, Shoji Takagaki et al. · The Journal of Antibiotics · 2010 · 29 citations

, , +12

FK317, a Novel Substituted Dihydrobenzoxazine, Exhibits Potent Antitumor Activity against Human Tumor Xenografts in Nude Mice

Yoshinori Naoe, Masamichi Inami, Sanae Matsumoto et al. · Japanese Journal of Cancer Research · 1998 · 23 citations · Full text

, , +15

Different Effects of FK317 on Multidrug‐resistant Tumor <i>in vivo</i> and <i>in vitro</i>

Yoshinori Naoe, Masamichi Inami, Shoji Takagaki et al. · Japanese Journal of Cancer Research · 1998 · 16 citations · Full text

, , +11

1–3 of 3